SUPN: Supernus Pharmaceuticals Inc

SUPN新闻

• 13:41 Supernus: The Merger Is Priced Like A Retreat, But Reads Like A Reverse Takeover (SUPN)
• 12:28 Biogen Stock: The Bull Case Is Extending Beyond Alzheimer's (Rating Upgrade) (NASDAQ:BIIB)
• 13:41 Can Biogen's Growth Portfolio Maintain Its Lead Over Legacy MS Drugs?
• 18:57 Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know
• 21:45 Is the Options Market Predicting a Spike in Supernus Pharmaceuticals Stock?
• 16:40 Indivior's Supernus Merger Could Broaden Its Growth Engine in 2026
• 14:48 Should Investors Buy INDV as Sublocade Growth Meets Rising Risks?
• 14:12 Should You Buy, Sell or Hold Biogen Stock After a 9% Rise in a Month?
• 15:40 SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?
• 08:46 New Strong Buy Stocks for August 7th
• 07:45 Best Value Stocks to Buy for August 7th
• 16:18 INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook
• 20:33 Stocks Settle Sharply Higher as Middle East Tensions Ease
• 19:59 Supernus Pharmaceuticals, Inc. (SUPN) M&A Call Transcript
• 19:44 Supernus And Indivior Merger: There May Be Some Skepticism, But I Have Faith In This Deal
• 15:20 Stocks Rally on Easing Geopolitical Risks and US Economic Strength
• 14:17 Stocks Supported by Easing Middle East Tensions
• 14:05 AbbVie: Strong Q2 And New Catalysts Keep Me Bullish (NYSE:ABBV)
• 13:30 Compared to Estimates, Supernus (SUPN) Q2 Earnings: A Look at Key Metrics
• 11:50 Supernus Pharmaceuticals (SUPN) Matches Q2 Earnings Estimates
• 14:00 Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for
• 15:09 Biogen's Q2 Earnings Beat, New Drugs Drive Sales, 2026 Guidance Raised
• 14:00 Supernus Pharmaceuticals (SUPN) Expected to Beat Earnings Estimates: Should You Buy?
• 16:10 Will Supernus (SUPN) Beat Estimates Again in Its Next Earnings Report?